Tokyo, Japan

Tetsuo Miyadera

This inventor holds 6 USPTO granted patents. Top assignee: Sankyo Company, Limited. Active years: 1977-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tetsuo Miyadera. Retrieved from https://idiyas.com/inventor/tetsuo-miyadera

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 45(Granted Patents)


Location History:

  • Tokyo, JA (1977)
  • Tokyo, JP (1979 - 1987)
  • Hiromachi, JP (1986 - 1988)

Company Filing History:


Years Active: 1977-1988

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Tetsuo Miyadera: Innovator in Antibiotic Compounds

Introduction

Tetsuo Miyadera is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of antibiotic compounds, holding a total of 6 patents. His work focuses on developing compounds that exhibit good antibiotic activity while minimizing renal toxicity.

Latest Patents

Miyadera's latest patents include innovative carbapenem compounds. These compounds are characterized by a specific formula that includes various functional groups, which enhance their antibiotic properties. Another notable patent involves 2-penem-3-carboxylic acid derivatives, which also demonstrate promising antibiotic activity.

Career Highlights

Miyadera is associated with Sankyo Company, Limited, where he has been instrumental in advancing antibiotic research. His expertise in the field has led to the development of compounds that are crucial in combating bacterial infections.

Collaborations

Miyadera has collaborated with notable colleagues such as Shinichi Sugawara and Yukio Sugimura. Their combined efforts have contributed to the success of various research projects and patent applications.

Conclusion

Tetsuo Miyadera's work in antibiotic compounds showcases his dedication to innovation in the pharmaceutical industry. His contributions are vital in the ongoing fight against bacterial infections, and his patents reflect his commitment to improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…